Horrell Capital Management, Inc. - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 392 filers reported holding ENCOMPASS HEALTH CORP in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Horrell Capital Management, Inc. ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$1,956
-2.2%
29,130
-1.3%
0.65%
+5.9%
Q2 2023$1,999
+25.2%
29,518
+0.0%
0.62%
+23.2%
Q1 2023$1,597
-9.0%
29,514
+0.6%
0.50%
-14.1%
Q4 2022$1,754
-99.9%
29,330
+0.6%
0.58%
+20.8%
Q3 2022$1,318,000
-18.6%
29,145
+0.9%
0.48%
-16.3%
Q2 2022$1,620,000
-22.3%
28,894
-1.5%
0.58%
-15.3%
Q1 2022$2,086,000
+7.9%
29,340
-1.0%
0.68%
+10.9%
Q4 2021$1,934,000
-12.6%
29,640
+0.5%
0.61%
-27.5%
Q3 2021$2,213,000
-3.5%
29,497
+0.3%
0.84%
-0.5%
Q2 2021$2,294,000
-11.8%
29,397
-7.5%
0.85%
-17.3%
Q1 2021$2,602,000
-0.6%
31,770
+0.3%
1.03%
-9.0%
Q4 2020$2,619,000
+27.8%
31,669
+0.4%
1.13%
+18.9%
Q3 2020$2,050,000
+5.3%
31,552
+0.4%
0.95%
-2.3%
Q2 2020$1,946,000
-2.5%
31,428
+0.9%
0.97%
-19.3%
Q1 2020$1,995,000
-7.1%
31,161
+0.6%
1.20%
+14.2%
Q4 2019$2,147,000
+9.9%
30,990
+0.4%
1.05%
+13.5%
Q3 2019$1,954,000
-0.3%
30,876
-0.2%
0.93%
-2.8%
Q2 2019$1,960,000
+7.7%
30,941
-0.7%
0.96%
+2.7%
Q1 2019$1,820,000
-4.9%
31,167
+0.4%
0.93%
-8.8%
Q4 2018$1,914,000
-20.2%
31,029
+0.9%
1.02%
-14.1%
Q3 2018$2,397,000
+15.6%
30,746
+0.4%
1.19%
+14.5%
Q2 2018$2,073,000
+23.3%
30,610
+4.1%
1.04%
+17.6%
Q1 2018$1,681,000
+18.8%
29,405
+2.7%
0.88%
+19.3%
Q4 2017$1,415,00028,6410.74%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Iron Triangle Partners LP 400,000$25,612,0009.91%
REINHART PARTNERS, LLC. 687,133$43,997,0004.26%
RK Capital 147,290$9,431,0004.24%
HealthCor Management, L.P. 1,525,809$97,698,0004.18%
Integral Health Asset Management, LLC 115,000$7,363,0003.24%
Sivik Global Healthcare LLC 32,500$7,733,0003.05%
Copeland Capital Management, LLC 635,514$40,692,0002.48%
Rock Springs Capital Management LP 815,000$52,184,0002.16%
Endurant Capital Management LP 55,614$3,561,0001.61%
Advantage Alpha Capital Partners LP 70,005$4,482,0001.60%
View complete list of ENCOMPASS HEALTH CORP shareholders